Inspire Medical Systems Securities Fraud Lawsuit

Inspire Medical Systems, a medical device manufacturer, is facing a securities fraud class action lawsuit filed by Bleichmar Fonti & Auld LLP. The lawsuit alleges that Inspire Medical Systems made misleading statements regarding the launch of its Inspire V device, which received FDA approval in August 2024. The company had assured investors of a smooth launch with high demand, but in August 2025, it disclosed significant delays and reduced its 2025 earnings per share guidance by over 80%. These delays were attributed to a lack of preparation among clinicians and payors, as well as weak demand due to customers having excess inventory of older devices. Following this disclosure, Inspire Medical Systems' stock price plummeted by more than 32%. Investors have until January 5, 2026, to seek appointment as lead plaintiff in the case, which is pending in the United States — United States District Court for the District of Minnesota.